Company XSPY PHAR Nasdaq Stockholm
Equities
SE0009973563
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Andersson
CEO | Chief Executive Officer | 57 | 01/06/01 |
Director of Finance/CFO | 52 | 08/02 | |
Thomas Walz
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Chief Tech/Sci/R&D Officer | 60 | 01/18/01 | |
Investor Relations Contact | 63 | 15/19/15 | |
Sales & Marketing | - | 15/22/15 | |
Andreas Konar
PRN | Corporate Officer/Principal | 75 | 01/10/01 |
Edward Jordan
PRN | Corporate Officer/Principal | 55 | 15/23/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 01/15/01 | |
Carl-Johan Spak
BRD | Director/Board Member | 68 | 01/15/01 |
Chairman | 70 | 19/22/19 | |
Director/Board Member | 55 | 01/17/01 | |
Christine Lind
BRD | Director/Board Member | 50 | 01/19/01 |
Director/Board Member | 66 | 01/21/01 | |
Robert Molander
BRD | Director/Board Member | 59 | 19/22/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,253,542 | 18,510,319 ( 59.23 %) | 0 | 59.23 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |